Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,361 to 1,380 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization. | Immunity | 2020 | 33098766 | PubTator, text mining | PubMed |
| Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation. | Cell Death Dis | 2020 | 33093461 | PubTator, text mining | PubMed |
| Dendritic Cells and Microglia Have Non-redundant Functions in the Inflamed Brain with Protective Effects of Type 1 cDCs. | Cell Rep | 2020 | 33086061 | PubTator, text mining | PubMed |
| Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy. | Sci Rep | 2020 | 33082438 | PubTator, text mining | PubMed |
| Epigenetic Control of IFN-γ Host Responses During Infection With Toxoplasma gondii. | Front Immunol | 2020 | 33072127 | PubTator, text mining | PubMed |
| [Immune Characteristics of Small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2020 | 33070515 | PubTator, text mining | PubMed |
| Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib-based combination therapy: A real-world experience of off-label ibrutinib use. | Cancer Med | 2020 | 33068336 | PubTator, text mining | PubMed |
| IL-17 Triggers Invasive and Migratory Properties in Human MSCs, while IFNy Favors their Immunosuppressive Capabilities: Implications for the "Licensing" Process. | Stem Cell Rev Rep | 2020 | 33067729 | PubTator, text mining | PubMed |
| A discrete subset of epigenetically primed human NK cells mediates antigen-specific immune responses. | Sci Immunol | 2020 | 33067380 | PubTator, text mining | PubMed |
| lncRNA involved in triptonide-induced cytotoxicity in mouse germ cells. | Reprod Toxicol | 2020 | 33045310 | PubTator, text mining | PubMed |
| CXCL4 Links Inflammation and Fibrosis by Reprogramming Monocyte-Derived Dendritic Cells in vitro. | Front Immunol | 2020 | 33042127 | PubTator, text mining | PubMed |
| ATP-Binding and Hydrolysis in Inflammasome Activation. | Molecules | 2020 | 33036374 | PubTator, text mining | PubMed |
| Integrative Analysis of Cell Crosstalk within Follicular Lymphoma Cell Niche: Towards a Definition of the FL Supportive Synapse. | Cancers (Basel) | 2020 | 33028033 | PubTator, text mining | PubMed |
| Role of Human Leukocyte Antigen System as A Predictive Biomarker for Checkpoint-Based Immunotherapy in Cancer Patients. | Int J Mol Sci | 2020 | 33023239 | PubTator, text mining | PubMed |
| The immune receptor CD300e negatively regulates T cell activation by impairing the STAT1-dependent antigen presentation. | Sci Rep | 2020 | 33020563 | PubTator, text mining | PubMed |
| Current status and future perspectives of HLA-edited induced pluripotent stem cells. | Inflamm Regen | 2020 | 33014207 | PubTator, text mining | PubMed |
| Roles of IFN-γ in tumor progression and regression: a review. | Biomark Res | 2020 | 33005420 | PubTator, text mining | PubMed |
| Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma. | J Transl Med | 2020 | 32993793 | PubTator, text mining | PubMed |
| Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18. | Front Immunol | 2020 | 32983099 | PubTator, text mining | PubMed |
| An Update on CARD Only Proteins (COPs) and PYD Only Proteins (POPs) as Inflammasome Regulators. | Int J Mol Sci | 2020 | 32962268 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=69